CONTEXT: In many disorders requiring steroid therapy, there is substantial decrease in bone mineral density. The association between steroid use and 25-hydroxyvitamin D [25(OH)D] deficiency has not been confirmed in large population-based studies, and currently there are no specific vitamin D recommendations for steroid users. OBJECTIVE: The aim of the study was to evaluate the association of serum 25(OH)D deficiency [defined as 25(OH)D <10 ng/ml] with oral steroid use. DESIGN: Cross-sectional analysis was performed using NHANES 2001-2006. SETTING: We analyzed a nationally representative sample of U.S. children and adults. PARTICIPANTS: The study sample consisted of children, adolescents, and adults from NHANES 2001-2006 (n = 22,650), representative of 286 million U.S. residents, with serum 25(OH)D levels and data on other potential confounders. MAIN OUTCOME MEASURE: We measured serum 25(OH)D levels below 10 ng/ml. RESULTS: A total of 181 individuals (0.9% of the population) used steroids within the past 30 d. Overall, 5% of the population had 25(OH)D levels below 10 ng/ml. Among steroid users, 11% had 25(OH)D levels below 10 ng/ml, compared to 5% among steroid nonusers (P = 0.009). The odds of having 25(OH)D deficiency were 2-fold higher in those who reported steroid use compared to those without steroid use [odds ratio (OR), 2.36; 95% confidence interval (CI), 1.25, 4.45]. This association remained after multivariable adjustment (OR, 2.21; 95% CI, 1.01, 4.85) and in a multivariable model using NHANES III data (OR, 1.88; 95% CI, 1.01, 3.48). CONCLUSION: Steroid use is independently associated with 25(OH)D deficiency in this nationally representative cohort limited by cross-sectional data. It suggests the need for screening and repletion in patients on chronic steroids.
CONTEXT: In many disorders requiring steroid therapy, there is substantial decrease in bone mineral density. The association between steroid use and 25-hydroxyvitamin D [25(OH)D] deficiency has not been confirmed in large population-based studies, and currently there are no specific vitamin D recommendations for steroid users. OBJECTIVE: The aim of the study was to evaluate the association of serum 25(OH)D deficiency [defined as 25(OH)D <10 ng/ml] with oral steroid use. DESIGN: Cross-sectional analysis was performed using NHANES 2001-2006. SETTING: We analyzed a nationally representative sample of U.S. children and adults. PARTICIPANTS: The study sample consisted of children, adolescents, and adults from NHANES 2001-2006 (n = 22,650), representative of 286 million U.S. residents, with serum 25(OH)D levels and data on other potential confounders. MAIN OUTCOME MEASURE: We measured serum 25(OH)D levels below 10 ng/ml. RESULTS: A total of 181 individuals (0.9% of the population) used steroids within the past 30 d. Overall, 5% of the population had 25(OH)D levels below 10 ng/ml. Among steroid users, 11% had 25(OH)D levels below 10 ng/ml, compared to 5% among steroid nonusers (P = 0.009). The odds of having 25(OH)D deficiency were 2-fold higher in those who reported steroid use compared to those without steroid use [odds ratio (OR), 2.36; 95% confidence interval (CI), 1.25, 4.45]. This association remained after multivariable adjustment (OR, 2.21; 95% CI, 1.01, 4.85) and in a multivariable model using NHANES III data (OR, 1.88; 95% CI, 1.01, 3.48). CONCLUSION:Steroid use is independently associated with 25(OH)D deficiency in this nationally representative cohort limited by cross-sectional data. It suggests the need for screening and repletion in patients on chronic steroids.
Authors: Timothy A Sentongo; Edisio J Semaeo; Nicolas Stettler; David A Piccoli; Virginia A Stallings; Babette S Zemel Journal: Am J Clin Nutr Date: 2002-11 Impact factor: 7.045
Authors: Sanna-Mari Aatsinki; Mahmoud-Sobhy Elkhwanky; Outi Kummu; Mikko Karpale; Marcin Buler; Pirkko Viitala; Valtteri Rinne; Maija Mutikainen; Pasi Tavi; Andras Franko; Rudolf J Wiesner; Kari T Chambers; Brian N Finck; Jukka Hakkola Journal: Diabetes Date: 2019-03-04 Impact factor: 9.461
Authors: M Tiefenbach; M Scheel; A Maier; M Gehlen; M Schwarz-Eywill; M Werner; U Siebers-Renelt; M Hammer Journal: Z Rheumatol Date: 2018-10 Impact factor: 1.372
Authors: S C Kaste; A Qi; K Smith; H Surprise; E Lovorn; J Boyett; R J Ferry; M V Relling; S A Shurtleff; C H Pui; L Carbone; M M Hudson; K K Ness Journal: Pediatr Blood Cancer Date: 2014-01-07 Impact factor: 3.167
Authors: Judy R Rees; Leila A Mott; Elizabeth L Barry; John A Baron; Roberd M Bostick; Jane C Figueiredo; Robert S Bresalier; Douglas J Robertson; Janet L Peacock Journal: J Nutr Date: 2016-09-28 Impact factor: 4.798
Authors: Apinya Lertratanakul; Peggy Wu; Alan Dyer; Murray Urowitz; Dafna Gladman; Paul Fortin; Sang-Cheol Bae; Caroline Gordon; Ann Clarke; Sasha Bernatsky; John G Hanly; David Isenberg; Anisur Rahman; Joan Merrill; Daniel J Wallace; Ellen Ginzler; Munther Khamashta; Ian Bruce; Ola Nived; Gunnar Sturfelt; Kristjan Steinsson; Susan Manzi; Mary Anne Dooley; Kenneth Kalunian; Michelle Petri; Cynthia Aranow; Josep Font; Ronald van Vollenhoven; Thomas Stoll; Rosalind Ramsey-Goldman Journal: Arthritis Care Res (Hoboken) Date: 2014-08 Impact factor: 4.794